Firms that have been successfully developing alternative products are now targets for traditional fund giants, as demonstrated by New York Life Investment Management's December acquisition of liquid alternative exchange-traded fund provider IndexIQ.

But one such firm, Denver-based 361 Capital, isn't seeking merger offers. 361 Capital's president and CEO, Tom Florence, explains in a conversation with Money Management Executive that his firm would rather focus on product development than deal with the potential pitfalls of being swallowed up by a larger corporate entity.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.